Register to receive a free U.S. Market Report Suite for Gynecological Devices report synopsis and brochure
According to a new series of reports on the U.S. gynecological device market by iData Research (www.idataresearch.com), the largest segment in the U.S. global endometrial ablation (GEA) market is represented by radiofrequency (RF) ablation. RF ablation is the preferred method by many physicians due to the speed of the procedure. It can be performed under local anesthetic and takes only a few minutes. Other procedures take up more of the physician’s time and increase patient stress and discomfort.
“One third of all hysterectomies performed every year in the United States are due to abnormal uterine bleeding,” explains Dr. Kamran Zamanian, CEO of iData. “Patients benefit from GEA devices with faster recovery times due to the minimally invasive nature of the procedure.”
Approximately 25% of women will be candidates for endometrial ablation procedures in their lifetime. Therefore, market penetration of GEA has the potential to grow by at least 200,000 women per year in the United States. While many of these women will receive either an alternative procedure or no treatment, there are a significant number of available patients that will continue to drive the endometrial ablation device market.
Continued growth in GEA procedures is being driven by the aging population, as heavy uterine bleeding occurs more commonly in mature women. However, many women are opting to delay their procedures or opt for more price sensitive options for heavy uterine bleeding. Moreover, private reimbursement payers are reportedly encouraging patients to choose less expensive methods to treat this condition such as hormonal therapy or IUDs.
In 2015, the leader of the global endometrial ablation market was Hologic. This is derived largely from their radiofrequency ablation device, NovaSure™. At 90 seconds, this device provides the fastest ablation method available to patients resulting in a five minute total procedure time. In addition, it has had a high satisfaction rate in clinical studies.
Ethicon, a Johnson & Johnson company, was the second leading competitor due to its well-known GYNECARE™ product, the THERMACHOICE® III uterine balloon therapy system. This was one of the first endometrial ablation methods available; many physicians, even if they have been trained on other methods, are familiar with how to perform this procedure. This has allowed Ethicon to achieve a high penetration rate in the office market.
Other competitors in the global endometrial ablation include Cooper Surgical with their Her Option™ system, which does not require IV sedation and Boston Scientific with their Genesys HTA™ system. The Genesys HTA™ system is the only endometrial ablation method performed as a hysteroscopic procedure, allowing the physician direct visualization during the treatment. This method, which uses heated saline to destroy the lining, has had excellent success rates in clinical studies, particularly over the long term.
For Further Information
More on the global endometrial ablation market in the United States can be found in a report suite published by iData Research entitled the U.S. Market Report Suite for Gynecological Devices. The suite covers reports on the following markets: Assisted Reproduction Technology Devices, Global Endometrial Ablation, Resectoscopic Endometrial Ablation & Resection Devices, Uterine Fibroid Embolization Devices, Hysteroscopes, Colposcopes, Female Sterilization Devices, Female Urinary Incontinence Slings, Pelvic Floor Electrical Stimulation Devices, Fluid Management Devices, Pelvic Organ Prolapse Repair Devices, and HSG Catheters.
The iData report series on gynecological devices covers the U.S., 15 countries in Europe and Asia-Pacific. Reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about gynecological device market data or procedure data, register online or email us at [email protected] for a U.S. Market Report Suite for Gynecological Devices brochure and synopsis.
About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by state, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.
About Reimbursement Tracker
iData Research’s Reimbursement Policy Tracker enables medical device, dental, pharmaceutical and healthcare professionals to receive real-time policy updates from hundreds of insurance companies and 60,000+ policies across all therapeutic areas in the United States.
About iData Research
iData Research (www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Laparoscopy, Urology, Gynecology, Vascular Access, Endoscopy, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Anesthesiology, Wound Management, Orthopedics, Ophthalmics, Dental Operatory Equipment and more.
Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.